For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is ...

The study, involving five patients, demonstrated the procedural efficiency and feasibility of AerWave's technology.

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic obstructive pulmonary disease (COPD). The Downtown Amarillo Library will be ...

The Downtown Amarillo Library will be temporarily closed for Wednesday evening and Thursday due to a city water main issue.

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

For the past 10 years, medications and inhalers began to help less and less with Rose Walsh’s breathing problems. Battling ...

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been ...

Verona Pharma (VRNA) stock in focus as company reports early sales for Q4 and 2024 thanks to its lung disease therapy ...